GlassScriptPhysician profile
Woodwin M Weeks
NPI 1053612325
$379.07
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $48.86 · 2021: $12.68 · 2022: $18.73 · 2023: $48.43 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $92.59 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $55.88 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $50.67 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.98 | 2019 | |
| Lilly USA, LLC | $26.34 | 2021-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.28 | 2019 | |
| Novo Nordisk INC | $22.58 | 2020 | |
| Abbvie INC. | $19.87 | 2019 | |
| Vapotherm INC | $17.20 | 2024 | Vapotherm |
| Sanofi Pasteur INC. | $14.74 | 2023 | |
| Amarin Pharma, INC. | $12.92 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Woodwin Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.